Viewing Study NCT00629967


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-04-11 @ 7:31 AM
Study NCT ID: NCT00629967
Status: COMPLETED
Last Update Posted: 2008-03-06
First Post: 2008-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: KMUH-IRB-94045
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: MING-LUNG YU
Old Organization: Kaohsiung Medical University Hospital

Collaborators